CYCN

Cyclerion Therapeutics (CYCN)

About Cyclerion Therapeutics (CYCN)

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.

Details

Daily high

$2.60

Daily low

$2.42

Price at open

$2.58

52 Week High

$5.25

52 Week Low

$1.75

Market cap

6.9M

Dividend yield

0.00%

Volume

4,328

Avg. volume

6,316

P/E ratio

-.49

Cyclerion Therapeutics News